The Malaria Diagnostics Market Size valued at USD 0.045 Billion in 2023. The Malaria Diagnostics industry is projected to rise from USD 0.047 Billion in 2024 to USD 0.082 Billion by 2032, exhibiting a compound yearly growth rate (CAGR) of 6.23% during the forecast period (2024 - 2032).
Malaria is a parasitic disease conveyed by the bite of infected anopheles mosquitoes. The Plasmodium parasite is transmitted by infected mosquitos. The parasite is released into the circulation after being bitten by an infected mosquito. When the human body becomes the parasite's host, the parasite grows in the liver. The adult parasite enters the bloodstream and infects red blood cells after a few days. Fever, vomiting, weakness, and headache are common symptoms of malaria in humans. In recent years, the global market for malaria diagnostics has grown dramatically.
The market's expansion is mostly due to developments in technological innovations in diagnostic instruments, as well as rising demand for treatment in malaria-endemic nations. Furthermore, factors such as increased collaboration between research institutes and industry, as well as government funding, are expected to support market expansion in the estimated timeframe. Factors such as a lack of solid import-export rules, lack of knowledge, a weak regulatory framework, and a lack of suitable monitoring standards at the country level, on the other hand, are expected to limit the market's growth in the next years.
The market of malaria diagnostics has been segmented on the basis of technology and end-user.
On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).
On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.
The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The malaria diagnostics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria diagnostics market in the Middle East and Africa has been segmented into the Middle East and Africa.
In the global market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. In 2016, global governments of malaria-endemic countries have invested USD 2.7 billion in malaria control and elimination efforts. The US was the largest contributor by providing USD 1 billion for the eradication of malaria.
The European market is expected to hold the least share due to the growing number of malaria-free countries in the region.
The market share in Asia-Pacific is also projected to experience growth in the near future due to access to optimal treatment facilities and growing demand for advanced technology, better adoption rate, increase in disposable income, and rising medical tourism. The Asia-Pacific remains to be the second largest burden of malaria globally with 22 malaria-endemic countries accounting for roughly 28 million cases and 45,000 deaths every year. The WHO figures say that in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the highest malaria burden accounting for 89% of all malaria cases in the region.
The market in the Middle East and Africa is expected to account for the smallest share of the global malaria diagnostics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities. Sub-Saharan Africa remains to bring an excessively high share of the global malaria burden on the Middle Eastern and African market. the region was home to 90% of malaria incidences and 92% of malaria deaths in 2015
Malaria Diagnostics Market Key Players
Some of the key players in the global market are
Recent Development
In March 2022, Audere, a digital health foundation dedicated to improving global health, announced a partnership with Medical Diagnostech, a designer and manufacturer of lateral flow fast diagnostic test kits. Medical Diagnostech's MD SARS-nCoV-2 Antigen Device1 will be paired with Audere's HealthPulsedigital companion app as part of the agreement. In February 2022, Kemri released the first domestically produced malaria and Covid-19 test kits. Both were freed by Health CAS Rashid Aman. Researchers of the Kenya Medical Research Institute created them. According to Aman, they have performed between three and four million Covid-19 tests thus far, and they are expensive. The ministry will assist the company with manufacturing and will be the product's primary consumer.
Americas
Europe
Asia-Pacific
Middle East & Africa
Intended Audience
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.045 billion |
| Market Size 2024 | USD 0.047 billion |
| Market Size 2032 | USD 0.082 billion |
| Compound Annual Growth Rate (CAGR) | 6.23% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 & 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Technique, End-User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, Bio-Rad Laboratories Inc |
| Key Market Opportunities | Increasing Investments and Advancements to Aid Market Growth |
| Key Market Dynamics | Growing Demand for Hyphenated Chromatography Techniques to Fuel Market Growth. Importance of chromatography in novel drug approvals |
Malaria Diagnostics Market Highlights:
Frequently Asked Questions (FAQ) :
lack of adequate medical facilities in emerging regions is the major restraint on the global Market.
Malaria Diagnostics Market is expected to exhibit a strong 6.23% CAGR over the forecast period from 2024 to 2032.
Growing awareness about malaria is the major driver for the market.
North America is anticipated to account for the largest share in the Global Market.
Leading players in the Malaria Diagnostics Market include Sysmex Partec, Access Bio, and Beckman Coulter, among others.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
